Clinical Trial

Respiratory Exacerbations in Children With Bronchopulmonary Dysplasia (BPD): A Case-Control Study

Study acronym: BPD-CC25
Recruiting
View on ClinicalTrials.gov →
Summary
This is an ambispective observational case-control study evaluating respiratory exacerbations in pediatric patients affected by bronchopulmonary dysplasia (BPD) compared with children without BPD. The study includes a retrospective cohort (January 2020 to September 2025) and a prospective cohort (from study approval to December 2030). Patients admitted to the Pediatric Emergency Department or Pediatric Unit for lower respiratory tract infections will be consecutively enrolled and managed according to standard clinical practice.
Trial Details
NCT Number NCT07666438
Lead Sponsor IRCCS Azienda Ospedaliero-Universitaria di Bologna
Conditions Severe Respiratory Exacerbation
Enrollment 800 participants
Start Date 2026-04-17
Primary Completion 2030-12-31 (estimated)
Study Completion 2030-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-24